Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II neoadjuvant axitinib for venous tumour thrombus in clear cell renal cell carcinoma
2017-000619-17Phase 2Unknown
- Sponsor
- NHS National Services Scotland
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of axitinib in clear cell renal cell carcinoma (ccRCC) and Tumor thrombus (TT), sponsored by NHS National Services Scotland. Status: unknown.
02
Drugs
axitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)Tumor thrombus (TT)
Beyond the preview
Go deeper on 2017-000619-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000619-17.